These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34978683)

  • 1. Childhood Medulloblastoma: An Overview.
    Suk Y; Gwynne WD; Burns I; Venugopal C; Singh SK
    Methods Mol Biol; 2022; 2423():1-12. PubMed ID: 34978683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medulloblastoma: what is the role of molecular genetics?
    Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMI1 is a therapeutic target in recurrent medulloblastoma.
    Bakhshinyan D; Venugopal C; Adile AA; Garg N; Manoranjan B; Hallett R; Wang X; Mahendram S; Vora P; Vijayakumar T; Subapanditha M; Singh M; Kameda-Smith MM; Qazi M; McFarlane N; Mann A; Ajani OA; Yarascavitch B; Ramaswamy V; Farooq H; Morrissy S; Cao L; Sydorenko N; Baiazitov R; Du W; Sheedy J; Weetall M; Moon YC; Lee CS; Kwiecien JM; Delaney KH; Doble B; Cho YJ; Mitra S; Kaplan D; Taylor MD; Davis TW; Singh SK
    Oncogene; 2019 Mar; 38(10):1702-1716. PubMed ID: 30348991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment of medulloblastoma: recent advances and future challenges.
    Rood BR; Macdonald TJ; Packer RJ
    Semin Oncol; 2004 Oct; 31(5):666-75. PubMed ID: 15497120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic insights into medulloblastoma relapse.
    Peterson K; Turos-Cabal M; Salvador AD; Palomo-Caturla I; Howell AJ; Vieira ME; Greiner SM; Barnoud T; Rodriguez-Blanco J
    Pharmacol Ther; 2024 Aug; 260():108673. PubMed ID: 38857789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates on Management of Adult Medulloblastoma.
    Majd N; Penas-Prado M
    Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medulloblastoma stem cells: modeling tumor heterogeneity.
    Manoranjan B; Venugopal C; McFarlane N; Doble BW; Dunn SE; Scheinemann K; Singh SK
    Cancer Lett; 2013 Sep; 338(1):23-31. PubMed ID: 22796365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
    Menyhárt O; Győrffy B
    Cancer Metastasis Rev; 2020 Mar; 39(1):211-233. PubMed ID: 31970590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies.
    Wang J; Garancher A; Ramaswamy V; Wechsler-Reya RJ
    Annu Rev Neurosci; 2018 Jul; 41():207-232. PubMed ID: 29641939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas.
    Lhermitte B; Blandin AF; Coca A; Guerin E; Durand A; Entz-Werlé N
    Neurochirurgie; 2021 Feb; 67(1):39-45. PubMed ID: 29776650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma.
    Li Y; Jiang T; Shao L; Liu Y; Zheng C; Zhong Y; Zhang J; Chang Q
    J Neurooncol; 2016 Sep; 129(3):423-431. PubMed ID: 27406588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric medulloblastoma in the molecular era: what are the surgical implications?
    Kameda-Smith MM
    Cancer Metastasis Rev; 2020 Mar; 39(1):235-243. PubMed ID: 32095940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medulloblastoma: recurrence and metastasis.
    Aref D; Croul S
    CNS Oncol; 2013 Jul; 2(4):377-85. PubMed ID: 25054581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
    Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
    Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulloblastoma: an Old Diagnosis with New Promises.
    Szalontay L; Khakoo Y
    Curr Oncol Rep; 2020 Jul; 22(9):90. PubMed ID: 32643099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview and recent advances in the targeting of medulloblastoma cancer stem cells.
    Paul MR; Zage PE
    Expert Rev Anticancer Ther; 2021 Sep; 21(9):957-974. PubMed ID: 34047251
    [No Abstract]   [Full Text] [Related]  

  • 18. Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile.
    Sadighi Z; Vats T; Khatua S
    J Child Neurol; 2012 Oct; 27(10):1302-7. PubMed ID: 22826514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Classification of Medulloblastoma.
    Kijima N; Kanemura Y
    Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SEOM clinical guideline for management of adult medulloblastoma (2020).
    Luque R; Benavides M; Del Barco S; Egaña L; García-Gómez J; Martínez-García M; Pérez-Segura P; Pineda E; Sepúlveda JM; Vieito M
    Clin Transl Oncol; 2021 May; 23(5):940-947. PubMed ID: 33792841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.